Fabian B T Kraus
Overview
Explore the profile of Fabian B T Kraus including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
19
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kraus F, Sultova E, Heinrich K, Jung A, Westphalen C, Tauber C, et al.
Int J Mol Sci
. 2024 Feb;
25(4).
PMID: 38397025
Advances in molecular tumor diagnostics have transformed cancer care. However, it remains unclear whether precision oncology has the same impact and transformative nature across all malignancies. We conducted a retrospective...
2.
Reichenbach J, Fraungruber P, Mayr D, Buschmann C, Kraus F, Topalov N, et al.
J Cancer Res Clin Oncol
. 2023 May;
149(11):8719-8728.
PMID: 37131060
Purpose: The significance of the non-classical G-protein-coupled estrogen receptor (GPER) as positive or negative prognostic factor for ovarian cancer patients remains still controversial. Recent results indicate that an imbalance of...
3.
Kraus F, Topalov N, Deuster E, Hysenaj I, Mayr D, Chelariu-Raicu A, et al.
J Cancer Res Clin Oncol
. 2022 Jun;
149(6):2501-2511.
PMID: 35751684
Purpose: Despite recent advances in the treatment of ovarian cancer (OC), long-term remissions remain scarce. For a targeted approach, prognostic markers are indispensable for predicting survival and treatment response. Given...
4.
Rataj F, Kraus F, Chaloupka M, Grassmann S, Heise C, Cadilha B, et al.
Front Immunol
. 2018 Sep;
9:1955.
PMID: 30214445
Interaction of the programmed death receptor 1 (PD-1) and its ligand, PD-L1, suppresses T cell activity and permits tumors to evade T cell-mediated immune surveillance. We have recently demonstrated that...